88832541
Mar 12, 2020
house mark for pharmaceutical preparations; nucleic acid medicines for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy
Pharmaceuticalsmedical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing
Computer and Scientific